Zdrowie i gospodarka · 23/09/2013

FDA Announces Public Meeting on Patient-Focused Drug Development for Fibromyalgia

The FDA is hosting a public meeting to gather patients' perspectives on fibromyalgia and its treatment options, as part of its efforts to improve patient outcomes under the Prescription Drug User Fee Act (PDUFA V)